ROTH CH ACQUISITION V CO (ROCL) Fundamental Analysis & Valuation

NASDAQ:ROCL • US77867R1005

9.88 USD
-0.88 (-8.18%)
At close: Dec 6, 2024
10.9 USD
+1.02 (+10.32%)
After Hours: 12/6/2024, 8:11:56 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ROCL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ROCL. ROCL was compared to 0 industry peers in the Unkown industry. ROCL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ROCL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. ROCL Profitability Analysis

1.1 Basic Checks

  • In the past year ROCL has reported negative net income.
  • In the past year ROCL has reported a negative cash flow from operations.
ROCL Yearly Net Income VS EBIT VS OCF VS FCFROCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 500K -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -7.13%
ROE -9.48%
ROIC N/A
ROA(3y)-0.02%
ROA(5y)N/A
ROE(3y)-0.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROCL Yearly ROA, ROE, ROICROCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -2 -4 -6 -8

1.3 Margins

  • ROCL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ROCL Yearly Profit, Operating, Gross MarginsROCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ROCL Health Analysis

2.1 Basic Checks

  • ROCL has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ROCL has a worse debt to assets ratio.
ROCL Yearly Shares OutstandingROCL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M
ROCL Yearly Total Debt VS Total AssetsROCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 6.77 indicates that ROCL is not in any danger for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.10 indicates that ROCL is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 6.77
ROIC/WACCN/A
WACCN/A
ROCL Yearly LT Debt VS Equity VS FCFROCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • ROCL has a Current Ratio of 4.04. This indicates that ROCL is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 4.04 indicates that ROCL has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.04
Quick Ratio 4.04
ROCL Yearly Current Assets VS Current LiabilitesROCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ROCL Growth Analysis

3.1 Past

  • ROCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2322.67%.
EPS 1Y (TTM)-2322.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. ROCL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ROCL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ROCL Price Earnings VS Forward Price EarningsROCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROCL Per share dataROCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ROCL Dividend Analysis

5.1 Amount

  • ROCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ROCL Fundamentals: All Metrics, Ratios and Statistics

ROTH CH ACQUISITION V CO

NASDAQ:ROCL (12/6/2024, 8:11:56 PM)

After market: 10.9 +1.02 (+10.32%)

9.88

-0.88 (-8.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners26.17%
Inst Owner Change0%
Ins Owners49.7%
Ins Owner Change0%
Market Cap48.61M
Revenue(TTM)N/A
Net Income(TTM)-1.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.6
P/tB 3.6
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0
BVpS2.75
TBVpS2.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.13%
ROE -9.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.02%
ROA(5y)N/A
ROE(3y)-0.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.04
Quick Ratio 4.04
Altman-Z 6.77
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2322.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.99%
OCF growth 3YN/A
OCF growth 5YN/A

ROTH CH ACQUISITION V CO / ROCL FAQ

What is the fundamental rating for ROCL stock?

ChartMill assigns a fundamental rating of 1 / 10 to ROCL.


What is the valuation status for ROCL stock?

ChartMill assigns a valuation rating of 0 / 10 to ROTH CH ACQUISITION V CO (ROCL). This can be considered as Overvalued.


Can you provide the profitability details for ROTH CH ACQUISITION V CO?

ROTH CH ACQUISITION V CO (ROCL) has a profitability rating of 0 / 10.


How financially healthy is ROTH CH ACQUISITION V CO?

The financial health rating of ROTH CH ACQUISITION V CO (ROCL) is 4 / 10.